City
Epaper

2 arthritis drugs show different results in Covid-19 trials

By IANS | Updated: April 28, 2020 22:25 IST

With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.

Open in App
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.

gb/arm

( With inputs from IANS )

Open in App

Related Stories

InternationalPakistan Army confirms India missile strikes in its territory, scramble jets in response

InternationalDavid Lammy hails UK-India trade deal as gateway to shared prosperity

InternationalManoj Kumar Mohapatra appointed as next Indian ambassador to Romania

Cricket"With rain coming in the shots were not easy to hit": Shubman Gill

Cricket"It is crime": MI captain Hardik Pandya's no-nonsense verdict on his no-ball fiasco against GT

Health Realted Stories

HealthShingles vaccine can protect heart health up to 8 years: Study

HealthStudy shows HIV prevalence rising in older adults, but prevention focusses youth

HealthJharkhand govt to withdraw order removing RIMS Director, HC disposes of petition

HealthElderly dementia patients in S. Korea hold assets worth 6.4 pc of GDP: Report

HealthHere’s how Ayurveda tourism is redefining wellness travel